(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 22.20%4.04B | 34.04%6.98B | 45.58%3.31B | -4.86%5.21B | -19.95%2.27B | -0.17%5.48B | 24.13%2.84B | -32.46%5.49B | -40.52%2.29B | 8.69%8.12B |
Operating income | 22.20%4.04B | 34.04%6.98B | 45.58%3.31B | -4.86%5.21B | -19.95%2.27B | -0.17%5.48B | 24.13%2.84B | -32.46%5.49B | -40.52%2.29B | 8.69%8.12B |
Operating expenses | -13.58%-1.63B | -7.34%-3.32B | -13.70%-1.44B | 6.72%-3.09B | 10.11%-1.27B | -7.34%-3.31B | -10.30%-1.41B | 14.89%-3.09B | -1.28B | -3.63B |
Gross profit | 28.84%2.41B | 72.97%3.67B | 85.65%1.87B | -2.01%2.12B | -29.64%1.01B | -9.83%2.16B | 41.60%1.43B | -46.63%2.4B | 1.01B | 4.5B |
Selling expenses | 29.40%-38.89M | -20.65%-129.15M | -43.84%-55.08M | 12.93%-107.04M | 30.21%-38.29M | -4.77%-122.94M | -0.31%-54.87M | 20.43%-117.35M | 91.41%-54.7M | 86.47%-147.47M |
Administrative expenses | -4.40%-464.31M | -15.24%-1.06B | -27.23%-444.72M | 0.20%-921.53M | 15.04%-349.55M | 0.72%-923.38M | -6.88%-411.41M | 10.24%-930.09M | ---384.94M | ---1.04B |
Research and development expenses | -56.95%-431.96M | -22.99%-863.04M | -26.97%-275.22M | 27.94%-701.71M | 26.19%-216.77M | -40.80%-973.81M | -9.35%-293.66M | 8.73%-691.62M | ---268.56M | ---757.73M |
Profit from asset sales | -99.38%16.49K | -98.04%2.66M | 2,469.24%2.65M | 16,069.78%135.98M | 252.61%103.34K | -7,292.05%-851.49K | -180.42%-67.71K | -96.42%11.84K | --84.2K | --330.88K |
Revaluation surplus | -92.88%484.5K | 85.60%68.31M | -66.10%6.8M | 270.65%36.81M | 702.52%20.06M | 241.74%9.93M | ---3.33M | 27.54%-7.01M | ---- | ---9.67M |
-Changes in the fair value of other assets | -92.88%484.5K | 85.60%68.31M | -66.10%6.8M | 270.65%36.81M | 702.52%20.06M | 241.74%9.93M | ---3.33M | 27.54%-7.01M | ---- | ---9.67M |
Impairment and provision | -50.06%59.64M | -393.59%-303.68M | 215.73%119.43M | -116.75%-61.52M | 74.35%-103.2M | 139.46%367.41M | 39.35%-402.32M | -1,984.76%-931.08M | ---663.36M | ---44.66M |
-Other impairment is provision | -50.06%59.64M | -393.59%-303.68M | 215.73%119.43M | -116.75%-61.52M | 74.35%-103.2M | 139.46%367.41M | 39.35%-402.32M | -1,984.76%-931.08M | ---663.36M | ---44.66M |
Special items of operating profit | -41.54%47.01M | 43.20%154.26M | 52.58%80.42M | -15.96%107.72M | -3.69%52.71M | -78.45%128.18M | -24.79%54.73M | 128.01%594.73M | 115.94%72.76M | 117.66%260.83M |
Operating profit | 21.17%1.54B | 170.76%1.45B | 276.40%1.27B | -6.51%536.58M | 18.54%336.57M | 144.81%573.93M | 188.14%283.92M | -91.24%234.44M | -120.74%-322.13M | 15.41%2.68B |
Financing cost | 9.48%78.65M | -6.91%151.73M | -12.03%71.84M | 67.04%162.99M | 92.19%81.67M | 7.94%97.58M | -30.14%42.49M | -18.11%90.4M | --60.83M | --110.4M |
Special items of earning before tax | -196.95%-7.93M | -78.73%7.56M | -81.58%8.18M | 566.68%35.56M | 3,665.23%44.42M | 28.63%-7.62M | -80.37%1.18M | -168.63%-10.68M | -59.62%6.01M | -75.59%15.56M |
Earning before tax | 19.22%1.61B | 119.30%1.61B | 191.11%1.35B | 10.73%735.14M | 41.23%462.66M | 111.32%663.88M | 228.32%327.59M | -88.79%314.16M | -115.07%-255.29M | 5.75%2.8B |
Tax | -64.43%-228.91M | -197.11%-164.26M | -1,935.98%-139.21M | -4.75%-55.29M | 79.08%-6.84M | -153.98%-52.78M | 35.92%-32.69M | 144.99%97.78M | 79.72%-51.01M | 19.10%-217.31M |
After-tax profit from continuing operations | 14.01%1.38B | 112.97%1.45B | 164.94%1.21B | 11.25%679.85M | 54.57%455.82M | 48.35%611.1M | 196.28%294.9M | -84.07%411.94M | -121.23%-306.29M | 8.55%2.59B |
Earning after tax | 14.01%1.38B | 112.97%1.45B | 164.94%1.21B | 11.25%679.85M | 54.57%455.82M | 48.35%611.1M | 196.28%294.9M | -84.07%411.94M | -121.23%-306.29M | 8.55%2.59B |
Minority profit | 32.00%9.59M | -7.34%48.92M | -43.15%7.27M | -11.71%52.8M | -35.12%12.79M | 21.71%59.8M | 16.65%19.71M | -17.43%49.14M | -13.60%16.9M | 5.07%59.51M |
Profit attributable to shareholders | 13.90%1.37B | 123.10%1.4B | 170.95%1.2B | 13.74%627.05M | 60.99%443.03M | 51.96%551.3M | 185.15%275.2M | -85.64%362.8M | -122.71%-323.19M | 8.64%2.53B |
Basic earnings per share | 14.63%0.47 | 128.57%0.48 | 173.33%0.41 | 10.53%0.21 | 66.67%0.15 | 58.33%0.19 | 181.82%0.09 | -86.21%0.12 | -122.45%-0.11 | 10.13%0.87 |
Diluted earnings per share | 14.63%0.47 | 128.57%0.48 | 173.33%0.41 | 10.53%0.21 | 66.67%0.15 | 58.33%0.19 | 181.82%0.09 | 0.12 | -122.45%-0.11 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data